AbCellera
cro source bien engineer protein engineering stot ers bam moot our protein engineering tool kit supports next generation antibody therapeutics such as constructs humanization optimization and most recently antibodies that enable the following therapeutic modalities tara bait a at peat protein scaffolding | AbCellera
Company
Deck Type
IPO
Deck date
December 2020
Slide
31 of 38
Other recent decks by AbCellera
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies